Recombinant Human CCL3L1/LD78 beta 509-MI-025 from R&D Systems, a Bio-Techne Brand | Biocompare.com

Be the first to write a review!

Citations:

Supplier Page from
R&D Systems, a Bio-Techne Brand for
Recombinant Human CCL3L1/LD78 beta

Product Specs
ItemRecombinant Human CCL3L1/LD78 beta
CompanyR&D Systems, a Bio-Techne Brand
Price $292.00Supplier Page View Company Product Page
Catalog Number509-MI-025
SpeciesHuman
Molecule NameCCL3L1/MIP-1 alpha Isoform LD78 beta
Size25 ug
NCBI Full Gene NameC-C motif chemokine ligand 3 like 3
NCBI Gene AliasesD17S1718, SCYA3L1, LD78BETA, 464.2, SCYA3L, G0S19-2, LD78
FormatLyophilized from a 0.2 µm filtered solution in Acetonitrile and TFA with BSA as a carrier protein
Purity>97%, by SDS-PAGE under reducing conditions and visualized by silver stain
Molecular Weight7.8 kDa
ApplicationsBioactivity
Conjugate/TagUnconjugated
Source/Expression SystemE. coli-derived Recombinant Human CCL3L1/LD78 beta
StorageUse a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 3 months, -20 to -70 °C under sterile conditions after reconstitution

Add to Compare List

R&D Systems, a Bio-Techne Brand

614 McKinley Place N.E.

Minneapolis, Minnesota 55413

United States

Phone: 1 (800) 343-7475
1 (612) 379-2956

Fax: 1 (612) 656-4400

Company Profile

Website: http://www.rndsystems.com

(1) A novel SARS-CoV-2 Beta RBD DNA vaccine directly targeted to antigen-presenting cells induces strong humoral and T cell responsesScientific reportsNovember 2, 2023Kuczkowska K, Bjerkan L, Stubsrud E, Husbyn HC, Chellappa S, Hauge A, Skarshaug R, Torgersen ML, Heim JB, Jørgensen MJ, et al.

(2) Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitorsNatureJuly 26, 2012Wilson TR, Fridlyand J, Yan Y, Penuel E, Burton L, Chan E, Peng J, Lin E, Wang Y, Sosman J, et al.

(3) Regulation of D6 chemokine scavenging activity by ligand- and Rab11-dependent surface up-regulationBloodAugust 1, 2008Bonecchi R, Borroni EM, Anselmo A, Doni A, Savino B, Mirolo M, Fabbri M, Jala VR, Haribabu B, Mantovani A, et al.

Be the First to Write a Review!